Journal
NUTRIENTS
Volume 14, Issue 20, Pages -Publisher
MDPI
DOI: 10.3390/nu14204411
Keywords
BCAA; branch chain amino acid; leucine; isoleucine; valine; type 2 diabetes mellitus; T2DM; insulin resistance; obese; obesity; overweight; BMI
Categories
Funding
- Novo Nordisk UK Research Foundation [1056410]
- Foundation De Drie Lichten in The Netherlands
- EMBO [9142]
Ask authors/readers for more resources
Recent studies have shown that elevated circulating branched chain amino acids (BCAA) are associated with the development of type 2 diabetes mellitus (T2DM) and obesity. This systematic review and meta-analysis found a significant positive association between BCAA concentrations and the risk of developing T2DM. The findings suggest that BCAAs may serve as potential early biomarkers for T2DM.
Introduction: Recent studies have concluded that elevated circulating branched chain amino acids (BCAA) are associated with the pathogenesis of type 2 diabetes mellitus (T2DM) and obesity. However, the development of this association over time and the quantification of the strength of this association for individual BCAAs prior to T2DM diagnosis remains unexplored. Methods: A systematic search was conducted using the Healthcare Databases Advance Search (HDAS) via the National Institute for Health and Care Excellence (NICE) website. The data sources included EMBASE, MEDLINE and PubMed for all papers from inception until November 2021. Nine studies were identified in this systematic review and meta-analysis. Stratification was based on follow-up times (0-6, 6-12 and 12 or more years) and controlling of body mass index (BMI) through the specific assessment of overweight cohorts was also undertaken. Results: The meta-analysis revealed a statistically significant positive association between BCAA concentrations and the development of T2DM, with valine OR = 2.08 (95% CI = 2.04-2.12, p < 0.00001), leucine OR = 2.25 (95% CI = 1.76-2.87, p < 0.00001) and isoleucine OR = 2.12, 95% CI = 2.00-2.25, p < 0.00001. In addition, we demonstrated a positive consistent temporal association between circulating BCAA levels and the risk of developing T2DM with differentials in the respective follow-up times of 0-6 years, 6-12 years and >= 12 years follow-up for valine (OR = 2.08, 1.86 and 2.14, p < 0.05 each), leucine (OR = 2.10, 2.25 and 2.16, p < 0.05 each) and isoleucine (OR = 2.12, 1.90 and 2.16, p < 0.05 each) demonstrated. Conclusion: Plasma BCAA concentrations are associated with T2DM incidence across all temporal subgroups. We suggest the potential utility of BCAAs as an early biomarker for T2DM irrespective of follow-up time.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available